We would like to hear from you.

Please use the following contact details:

For media enquiries: lisa.baderoon@immupharma.com

For investor enquiries: investors@immupharma.com

Note to patients

ImmuPharma’s drug candidates are still in development and are not currently available for use by patients. If you are concerned that you may be affected by any of the conditions described on this website, please contact your family doctor or specialist for advice.